Global ADC Platform Market Research Report 2023

Publication ID:

PB510235696

Publication Date:

October 17, 2023

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The ADC platform is designed to generate ADCs with superior safety profiles, sustainable payload delivery and release in tumors, and efficient bystander killing of antigen-low and negative cells.
The global ADC Platform market is projected to reach US$ 13840 million in 2029, increasing from US$ 4400 million in 2022, with the CAGR of 18.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole ADC Platform 91制片厂.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global ADC Platform market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Nerviano Medical Sciences
Creative Biolabs
Citrix Systems
AstraZeneca
Mersana
Seagen
ADC Therapeutics
Biocytogen
Heidelberg Pharma AG
Sutro
Synaffix
Genovis Group
Adcendo
WuXi Discovery Services
Daiichi Sankyo
Lonza
LEPU BIOPHARMA
HUABO BIOPHARMA
WuXi Biologics
Segment by Type
Software Platform
Serve
Segment by Application
Oncology
BioPharmaceuticals
Rare Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The ADC Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADC Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Software Platform
1.2.3 Serve
1.3 Market by Application
1.3.1 Global ADC Platform Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 BioPharmaceuticals
1.3.4 Rare Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADC Platform Market Perspective (2018-2029)
2.2 ADC Platform Growth Trends by Region
2.2.1 Global ADC Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 ADC Platform Historic Market Size by Region (2018-2023)
2.2.3 ADC Platform Forecasted Market Size by Region (2024-2029)
2.3 ADC Platform Market Dynamics
2.3.1 ADC Platform Industry Trends
2.3.2 ADC Platform Market Drivers
2.3.3 ADC Platform Market Challenges
2.3.4 ADC Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADC Platform Players by Revenue
3.1.1 Global Top ADC Platform Players by Revenue (2018-2023)
3.1.2 Global ADC Platform Revenue Market Share by Players (2018-2023)
3.2 Global ADC Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ADC Platform Revenue
3.4 Global ADC Platform Market Concentration Ratio
3.4.1 Global ADC Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADC Platform Revenue in 2022
3.5 ADC Platform Key Players Head office and Area Served
3.6 Key Players ADC Platform Product Solution and Service
3.7 Date of Enter into ADC Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ADC Platform Breakdown Data by Type
4.1 Global ADC Platform Historic Market Size by Type (2018-2023)
4.2 Global ADC Platform Forecasted Market Size by Type (2024-2029)
5 ADC Platform Breakdown Data by Application
5.1 Global ADC Platform Historic Market Size by Application (2018-2023)
5.2 Global ADC Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America ADC Platform Market Size (2018-2029)
6.2 North America ADC Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America ADC Platform Market Size by Country (2018-2023)
6.4 North America ADC Platform Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADC Platform Market Size (2018-2029)
7.2 Europe ADC Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe ADC Platform Market Size by Country (2018-2023)
7.4 Europe ADC Platform Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADC Platform Market Size (2018-2029)
8.2 Asia-Pacific ADC Platform Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific ADC Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific ADC Platform Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADC Platform Market Size (2018-2029)
9.2 Latin America ADC Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America ADC Platform Market Size by Country (2018-2023)
9.4 Latin America ADC Platform Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADC Platform Market Size (2018-2029)
10.2 Middle East & Africa ADC Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa ADC Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa ADC Platform Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nerviano Medical Sciences
11.1.1 Nerviano Medical Sciences Company Detail
11.1.2 Nerviano Medical Sciences Business Overview
11.1.3 Nerviano Medical Sciences ADC Platform Introduction
11.1.4 Nerviano Medical Sciences Revenue in ADC Platform Business (2018-2023)
11.1.5 Nerviano Medical Sciences Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Detail
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs ADC Platform Introduction
11.2.4 Creative Biolabs Revenue in ADC Platform Business (2018-2023)
11.2.5 Creative Biolabs Recent Development
11.3 Citrix Systems
11.3.1 Citrix Systems Company Detail
11.3.2 Citrix Systems Business Overview
11.3.3 Citrix Systems ADC Platform Introduction
11.3.4 Citrix Systems Revenue in ADC Platform Business (2018-2023)
11.3.5 Citrix Systems Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca ADC Platform Introduction
11.4.4 AstraZeneca Revenue in ADC Platform Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Mersana
11.5.1 Mersana Company Detail
11.5.2 Mersana Business Overview
11.5.3 Mersana ADC Platform Introduction
11.5.4 Mersana Revenue in ADC Platform Business (2018-2023)
11.5.5 Mersana Recent Development
11.6 Seagen
11.6.1 Seagen Company Detail
11.6.2 Seagen Business Overview
11.6.3 Seagen ADC Platform Introduction
11.6.4 Seagen Revenue in ADC Platform Business (2018-2023)
11.6.5 Seagen Recent Development
11.7 ADC Therapeutics
11.7.1 ADC Therapeutics Company Detail
11.7.2 ADC Therapeutics Business Overview
11.7.3 ADC Therapeutics ADC Platform Introduction
11.7.4 ADC Therapeutics Revenue in ADC Platform Business (2018-2023)
11.7.5 ADC Therapeutics Recent Development
11.8 Biocytogen
11.8.1 Biocytogen Company Detail
11.8.2 Biocytogen Business Overview
11.8.3 Biocytogen ADC Platform Introduction
11.8.4 Biocytogen Revenue in ADC Platform Business (2018-2023)
11.8.5 Biocytogen Recent Development
11.9 Heidelberg Pharma AG
11.9.1 Heidelberg Pharma AG Company Detail
11.9.2 Heidelberg Pharma AG Business Overview
11.9.3 Heidelberg Pharma AG ADC Platform Introduction
11.9.4 Heidelberg Pharma AG Revenue in ADC Platform Business (2018-2023)
11.9.5 Heidelberg Pharma AG Recent Development
11.10 Sutro
11.10.1 Sutro Company Detail
11.10.2 Sutro Business Overview
11.10.3 Sutro ADC Platform Introduction
11.10.4 Sutro Revenue in ADC Platform Business (2018-2023)
11.10.5 Sutro Recent Development
11.11 Synaffix
11.11.1 Synaffix Company Detail
11.11.2 Synaffix Business Overview
11.11.3 Synaffix ADC Platform Introduction
11.11.4 Synaffix Revenue in ADC Platform Business (2018-2023)
11.11.5 Synaffix Recent Development
11.12 Genovis Group
11.12.1 Genovis Group Company Detail
11.12.2 Genovis Group Business Overview
11.12.3 Genovis Group ADC Platform Introduction
11.12.4 Genovis Group Revenue in ADC Platform Business (2018-2023)
11.12.5 Genovis Group Recent Development
11.13 Adcendo
11.13.1 Adcendo Company Detail
11.13.2 Adcendo Business Overview
11.13.3 Adcendo ADC Platform Introduction
11.13.4 Adcendo Revenue in ADC Platform Business (2018-2023)
11.13.5 Adcendo Recent Development
11.14 WuXi Discovery Services
11.14.1 WuXi Discovery Services Company Detail
11.14.2 WuXi Discovery Services Business Overview
11.14.3 WuXi Discovery Services ADC Platform Introduction
11.14.4 WuXi Discovery Services Revenue in ADC Platform Business (2018-2023)
11.14.5 WuXi Discovery Services Recent Development
11.15 Daiichi Sankyo
11.15.1 Daiichi Sankyo Company Detail
11.15.2 Daiichi Sankyo Business Overview
11.15.3 Daiichi Sankyo ADC Platform Introduction
11.15.4 Daiichi Sankyo Revenue in ADC Platform Business (2018-2023)
11.15.5 Daiichi Sankyo Recent Development
11.16 Lonza
11.16.1 Lonza Company Detail
11.16.2 Lonza Business Overview
11.16.3 Lonza ADC Platform Introduction
11.16.4 Lonza Revenue in ADC Platform Business (2018-2023)
11.16.5 Lonza Recent Development
11.17 LEPU BIOPHARMA
11.17.1 LEPU BIOPHARMA Company Detail
11.17.2 LEPU BIOPHARMA Business Overview
11.17.3 LEPU BIOPHARMA ADC Platform Introduction
11.17.4 LEPU BIOPHARMA Revenue in ADC Platform Business (2018-2023)
11.17.5 LEPU BIOPHARMA Recent Development
11.18 HUABO BIOPHARMA
11.18.1 HUABO BIOPHARMA Company Detail
11.18.2 HUABO BIOPHARMA Business Overview
11.18.3 HUABO BIOPHARMA ADC Platform Introduction
11.18.4 HUABO BIOPHARMA Revenue in ADC Platform Business (2018-2023)
11.18.5 HUABO BIOPHARMA Recent Development
11.19 WuXi Biologics
11.19.1 WuXi Biologics Company Detail
11.19.2 WuXi Biologics Business Overview
11.19.3 WuXi Biologics ADC Platform Introduction
11.19.4 WuXi Biologics Revenue in ADC Platform Business (2018-2023)
11.19.5 WuXi Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Nerviano Medical Sciences
Creative Biolabs
Citrix Systems
AstraZeneca
Mersana
Seagen
ADC Therapeutics
Biocytogen
Heidelberg Pharma AG
Sutro
Synaffix
Genovis Group
Adcendo
WuXi Discovery Services
Daiichi Sankyo
Lonza
LEPU BIOPHARMA
HUABO BIOPHARMA
WuXi Biologics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.